8-K: Bluejay Diagnostics Stockholders Approve Potential Reverse Stock Splits, Re-elect Directors at Annual Meeting

Bluejay Diagnostics, Inc. announced the results of its 2025 annual meeting, where stockholders re-elected all directors and approved proposals for potential reverse stock splits.

Summary

• Bluejay Diagnostics, Inc. held its 2025 annual meeting of stockholders on June 18, 2025.
• As of the record date, May 15, 2025, there were 1,494,182 shares of common stock issued and outstanding and entitled to vote, with 616,134 shares present, constituting a quorum.
• Stockholders re-elected Donald Chase, Neil Dey, Svetlana Dey, Douglas Wurth, and Fred Zeidman to serve as directors until the 2026 annual meeting.
• A proposal to amend the company's certificate of incorporation to effect a reverse stock split between 1-for-2 and 1-for-20 was approved by stockholders (420,241 For, 188,129 Against, 7,764 Abstentions). The Board retains sole discretion on whether to proceed, the exact ratio, and timing (not later than June 18, 2026).
• An additional proposal for a further reverse stock split, also between 1-for-2 and 1-for-20, was also approved (426,669 For, 181,699 Against, 7,766 Abstentions). This additional split can only be implemented after the first reverse stock split.
• The appointment of Wolf & Company, P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified by stockholders (383,236 For, 86,011 Against, 146,887 Abstentions).

Sentiment

Score: 4

Explanation: The re-election of directors and auditor ratification are routine and positive for continuity. However, the approval of reverse stock splits, while providing flexibility, often signals underlying issues with the company's stock price performance, which is generally a negative indicator for investors. The discretion given to the board also introduces uncertainty.

Positives

• The re-election of all incumbent directors ensures continuity of the current board leadership and strategic direction.
• Ratification of Wolf & Company, P.C. as the independent auditor provides assurance of continued financial oversight and compliance.
• Stockholder approval of the reverse stock split proposals provides the Board with the necessary flexibility to potentially address stock price requirements for exchange listing or improve market perception.

Negatives

• The necessity for potential reverse stock splits often indicates a low share price, which can be perceived as a negative signal regarding the company's market valuation or underlying financial health.
• A notable number of 'Votes Withheld' for director elections (e.g., Donald Chase had 145,772 votes withheld) and 'Broker Non-Votes' (383,644 for all directors) suggests a portion of shareholders did not actively support the re-election or were disengaged.
• A significant number of votes against the reverse stock split proposals (188,129 against Proposal 2 and 181,699 against Proposal 3) indicates some shareholder dissent regarding these corporate actions.

Risks

• The Board of Directors has sole discretion on whether to proceed with the approved reverse stock splits, the exact timing, and the specific ratio, introducing uncertainty for investors regarding the implementation of these actions.
• The reverse stock splits may not be implemented if the Board decides against it, which could leave the company's stock price at a level that might risk its Nasdaq listing (though not explicitly stated as the reason for the split, it's a common underlying risk).
• The additional reverse stock split is contingent on the first one being implemented, adding another layer of conditionality and potential for non-execution.

Future Outlook

The Board of Directors retains sole discretion to determine whether to proceed with the approved reverse stock splits, their exact timing, and the specific ratio, with the effective time not later than June 18, 2026. The additional reverse stock split is contingent upon the implementation of the first one.

Management Comments

• Neil Dey, President and Chief Executive Officer, signed the report on behalf of the company.

Industry Context

Reverse stock splits are a common corporate action, particularly for companies whose stock price has fallen significantly, often below minimum exchange listing requirements (e.g., Nasdaq's $1.00 bid price rule). This action aims to increase the per-share price, potentially improving market perception and maintaining listing compliance, which is a frequent challenge for smaller or developing companies in the diagnostics industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Directly impacted by the potential reverse stock splits, which will reduce the number of shares outstanding and proportionally increase the per-share price. This could affect liquidity and market perception.
• Management/Board: The re-election of directors provides continuity. The approval of reverse stock splits gives the Board significant discretion and tools to manage the company's stock structure and potentially address listing compliance.

Next Steps

• The Board of Directors will decide whether to proceed with the reverse stock splits, their exact timing, and the specific ratio.
• If implemented, the first reverse stock split must occur by June 18, 2026.
• The additional reverse stock split can only be implemented after the first one.

Key Dates

Keywords

Bluejay Diagnostics, BJDX, SEC filing, 8-K, annual meeting, stockholders, reverse stock split, director election, corporate governance, Nasdaq, auditor ratification